Hasso-Plattner-Institut25 Jahre HPI
Hasso-Plattner-Institut25 Jahre HPI
  • de



Digital Health: New Neuland-Podcast Episode on “New Approaches to Clinical Trials”

In the new episode of the HPI-Podcast "New Approaches to Clinical Trials", Prof. Dr. Ariel Dora Stern, Visiting Scholar for Digital Health Economics and Policy at the HPI and Associate Professor of Business Administration at the Harvard Business School at Harvard University, and Prof. Dr. Erwin Böttinger, Professor of Digital Health - Personalized Medicine at the HPI, meet up with host Leon Stebe. They talk about digital innovations in the health sector and discuss how clinical trials can benefit from those and be made more efficient and patient-friendly.

HPI-Wissenspodcast "Neuland"

Clinical trials are a vital part of clinical research and contribute to medical progress. They address new ways to prevent, detect or treat diseases and collect clinical data from patients with the aim of expanding medical knowledge and exploring new therapies and treatments.

Currently, the effort required for many clinical studies is very high - for participants as well as those who are conducting the research. This takes the form of long commuting journeys, long waiting times at the medical centre and time intensive implementation. Both experts agree that clinical trials can be made smarter, faster, less expensive and especially more patient-oriented in the future. Digital tools and technologies present a variety of opportunities to facilitate clinical trials and make them more efficient. A good example for this can be seen in wearables or sensor-based technologies. However, when it comes to the use of data in clinical research and issues associated with data protection in Germany there are still some hurdles to overcome.